Jamil Khurram

CIK 00020323451 companyNORCROSS, GA

SEC Profile

Transactions

Companies

Filings

CIK

0002032345

Recent Transactions

34 trades

Award
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Unit
2026-01-16+100,000→ 100,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2026-01-16+65,000→ 65,000 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-06$3.65/sh−21,446→ 0 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2026-01-05$3.90/sh−25,499→ 21,446 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-02$4.20/sh−13,055→ 46,945 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2026-01-02+60,000→ 60,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Unit
2026-01-01−60,000→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-31$1.23/sh+8,125→ 8,125 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-31$4.07/sh−8,125→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-12-31−8,125→ 40,625 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-17$7.04/sh−4,479→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-17$2.20/sh+6,463→ 6,463 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-17$7.04/sh−6,463→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-17$2.50/sh+8,500→ 8,500 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-12-17$7.04/sh−8,500→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-12-17−6,463→ 102,037 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-12-17−8,500→ 50,000 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-13$5.47/sh−41,500→ 4,479 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-13$2.50/sh+41,500→ 45,979 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-13$5.47/sh−41,500→ 4,479 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-13$1.23/sh+16,250→ 20,729 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common stock
2025-11-13$5.47/sh−16,250→ 4,479 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-13−41,500→ 108,500 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-13−41,500→ 58,500 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-13$2.20/sh+41,500→ 45,979 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Stock option (right to buy)
2025-11-13−16,250→ 48,750 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2025-11-13$5.47/sh−21,867→ 4,479 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2025-01-23+65,000→ 65,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Unit
2025-01-23+60,000→ 60,000 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Units
2024-12-23+40,000→ 0 total
Exercise/Conversion
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2024-12-23+40,000→ 40,000 total
Sale
GALECTIN THERAPEUTICS INC$GALT
Common Stock
2024-12-23$0.88/sh−13,654→ 26,346 total
Award
GALECTIN THERAPEUTICS INC$GALT
Stock Option (right to buy)
2024-08-01+100,000→ 100,000 total
Award
GALECTIN THERAPEUTICS INC$GALT
Restricted Stock Unit
2024-08-01+10,000→ 10,000 total

Companies

GALECTIN THERAPEUTICS INC
Chief Medical Officer
$GALT

Recent Filings

Address

4960 PEACHTREE INDUSTRIAL BLVD SUITE 240

NORCROSS, GA, 30071

View on SEC.gov